The peripheral myelin protein 22 kDa (PMP22) gene is amplified in cell lines derived from glioma and osteogenic sarcoma: A new candidate for an oncogene?

International Journal of Oncology

Volumn 10, Issue 5, 1997, Pages 915-919

  Liehr, T ^a   Park, O ^a   Feuerstein, B G ^b   Gebhart, E ^a   Rautenstrauss, B ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

amplification; FISH; glioma; oncogene; osteogenic sarcoma; PMP22

Indexed keywords

MYELIN; PERIPHERAL MYELIN PROTEIN 22; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; GLIOMA; HUMAN; HUMAN CELL; ONCOGENE; OSTEOSARCOMA; PRIORITY JOURNAL;

EID: 0030914187     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lupski JR: Molecular genetics of Charcot-Marie-Tooth disease and related peripheral neuropathies. In: Textbook of Molecular Medicine. Jameson JL (ed). Blackwell Scientific, Cambridge, MA, 1996.
2. Schneider C, King RM and Philipson L: Genes specifically expressed at growth arrest of mammalian cells. Cell 54: 787-793, 1988.
3. Manfioletti G, Ruaro ME, Del Sal G, Philipson L and Schneider C: A growth arrest-specific (gas) gene codes for a membrane protein. Mol Cell Biol 10: 2924-2930, 1990.
4. Baechner D, Liehr T, Hameister H, Altenberger H, Grehl H, Suter U and Rautenstrauss B: Widespread expression of the peripheral myelin protein-22 gene (pmp22) in neural and nonneural tissues during murine development. J Neurosci Res 42: 733-741, 1995.
5. Suter U, Snipes GJ, Schoener-Scott R, Welcher AA, Pareek S, Lupski JR, Murphy RA, Shooter EM and Patcl PI: Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J Biol Chem 269: 25795-25808, 1994.
6. Bosse F, Zoidl G, Wilms S, Gillen CP, Kuhn HG and Müller HW: Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination. J Neurosci Res 37: 529-537, 1994.
7. Zoidl G, Blass-Kampmann S, D'Urso D, Schmalenbach C and Müller HW: Retroviral gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J 14: 1122-1128, 1995.
8. Re FC, Manenti G, Borello M, Colombo MP, Fisher JH, Pierotti MA, Della Porta G and Dragani TA: Multiple molecular alterations in mouse lung tumors. Mol Carcinogen 5: 155-160, 1992.
9. Chance PF, Abbas N, Lensch MW, Pentoa MW, Roa BB, Patel PI and Lupski JR: Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet 3: 223-228, 1994.
10. Lupski JR: DNA diagnosis for Charcot-Marie-Tooth disease and related inherited neuropathies. Clin Chem 42: 995-998, 1996.
11. Reiter LT, Murakami T, Koeuth T, Pentao L, Muzny DM, Gibbs RA and Lupski JR: A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nature Genet 12: 288-297, 1996.
12. Kiyosawa H and Chance P: Primate origin of the CMTIA-REP repeat and analysis of a putative transposon-associated recombinational hotspot. Hum Mol Genet 5: 745-753, 1996.
13. Adlkofer K, Martini R, Aguzzi A, Zielasek J, Toyka KV and Suter U: Hypermyelination and demyelinating neuropathy in Pmp22-deficient mice. Nature Genet 11: 274-280, 1995.
14. Huxley C, Passage E, Manson A, Putzu G, Figarella-Branger D, Pellissier JF and Fontes M: Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 5: 563-569, 1996.
15. Magyar JP, Martini R, Ruelicke T, Aguzzi A, Adlkofer K, Dembic Z, Zielasek J, Toyka KV and Suter U: Impaired differentiation of Schwann cells in transgenetic mice with increased PMP22 gene dosage. J Neurosci 16: 5351-5360, 1996.